Cat.No:GM-83073AB
Product:Human IgG1 Isotype Control(Anti-MOPC-21)
Cat.No:GM-83073AB
Product:Human IgG1 Isotype Control(Anti-MOPC-21)
GM-83073AB-1mg 1mg
GM-83073AB-5mg 5mg
GM-83073AB-25mg 25mg
GM-83073AB-50mg 50mg
GM-83073AB-100mg 100mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target /
Clone /
Alternative Names /
Sourcellsotype Monoclonal Human lgG1 (KEEM),kappa
Application Negative control
Description A homologous control antibody is an antibody that is used to control the target antibody in an experiment. The homologous control antibody should have the same immunoglobulin type and concentration as the test antibody, but not have the same specificity as the target antibody. lt is often used to help researchers distinguish between non-specific signals and background signals in experiments to ensure the accuracy and reliability of experimental results.
Formulation Phosphate-buffered solution, pH 7.2.
Cat.No:GM-83073AB
Product:Human IgG1 Isotype Control(Anti-MOPC-21)
GM-83073AB-1mg 1mg
GM-83073AB-5mg 5mg
GM-83073AB-25mg 25mg
GM-83073AB-50mg 50mg
GM-83073AB-100mg 100mg
Expression System CHO
Aggregation < 5% as determined by SEC-HPLC
Purity >95% as determined by SDS-PAGE
Endotoxin <1 EU/mg, determined by LAL gel clotting assay
Sterility 0.22 μm Filtered
Target /
Clone /
Alternative Names /
Sourcellsotype Monoclonal Human lgG1 (KEEM),kappa
Application Negative control
Description A homologous control antibody is an antibody that is used to control the target antibody in an experiment. The homologous control antibody should have the same immunoglobulin type and concentration as the test antibody, but not have the same specificity as the target antibody. lt is often used to help researchers distinguish between non-specific signals and background signals in experiments to ensure the accuracy and reliability of experimental results.
Formulation Phosphate-buffered solution, pH 7.2.